The Multiple Myeloma Research Foundation's evolving focus on drug R&D

Article metrics

The Multiple Myeloma Research Foundation (MMRF) has developed innovative, collaborative business models to reshape the R&D enterprise with the single-minded focus of accelerating the development of new treatments for patients to extend their lives and lead to a cure.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Dilts, D. & Sandler, A. J. Clin. Oncol. 24, 4545–4551 (2006).

  2. 2

    Wear, S. et al. Proc. American Society of Hematology, San Diego, CA, Dec. 2011 (Abstract #1024)

  3. 3

    Chapman, M.A. et al. Nature 471, 467–472 (2011).

Download references

Author information

Correspondence to Kathy Giusti.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Giusti, K. The Multiple Myeloma Research Foundation's evolving focus on drug R&D. Nat Biotechnol 30, 600–603 (2012) doi:10.1038/nbt.2297

Download citation

Further reading